|
ANKRD36BP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.780800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.526400E-02 |
| Normal-vs-Stage2 |
9.914200E-01 |
| Normal-vs-Stage3 |
2.976400E-01 |
| Normal-vs-Stage4 |
2.429900E-02 |
| Stage1-vs-Stage2 |
2.866200E-01 |
| Stage1-vs-Stage3 |
1.272210E-02 |
| Stage1-vs-Stage4 |
7.164400E-04 |
| Stage2-vs-Stage3 |
4.667200E-01 |
| Stage2-vs-Stage4 |
1.027550E-01 |
| Stage3-vs-Stage4 |
2.519200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.267400E-01 |
| Normal-vs-AfricanAmerican |
2.704100E-03 |
| Normal-vs-Asian |
1.165570E-01 |
| Caucasian-vs-AfricanAmerican |
4.364700E-04 |
| Caucasian-vs-Asian |
3.762100E-02 |
| AfricanAmerican-vs-Asian |
3.608300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.362800E-01 |
| Normal-vs-Female |
2.642400E-01 |
| Male-vs-Female |
1.025980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.826170E-01 |
| Normal-vs-Age(41-60Yrs) |
4.244800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.754600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.232600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.331370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.852800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.979400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.722800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.297800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.108000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.319600E-01 |
| Normal-vs-Grade 2 |
1.547200E-01 |
| Normal-vs-Grade 3 |
7.651400E-01 |
| Normal-vs-Grade 4 |
3.773300E-04 |
| Grade 1-vs-Grade 2 |
8.870200E-01 |
| Grade 1-vs-Grade 3 |
4.808000E-01 |
| Grade 1-vs-Grade 4 |
1.221930E-02 |
| Grade 2-vs-Grade 3 |
2.862800E-01 |
| Grade 2-vs-Grade 4 |
1.7756000000313E-06 |
| Grade 3-vs-Grade 4 |
2.187400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.440300E-04 |
| Normal-vs-ccB subtype |
2.354800E-01 |
| ccA subtype-vs-ccB subtype |
3.60310000002695E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.280800E-01 |
| Normal-vs-N1 |
9.663000E-01 |
| N0-vs-N1 |
7.447800E-01 |
|
|
